Ra Capital Management, L.P. An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

RA CAPITAL MANAGEMENT, L.P. Transaction History

Date Transaction Value Shares Traded Form
Aug 09 2024
SELL
Open market or private sale
$3,807,101 $1.08 p/Share
3,525,094
Aug 18 2023
BUY
Open market or private purchase
$16,000,002 $9.0 p/Share
1,777,778
Aug 04 2022
BUY
Open market or private purchase
$799 $7.99 p/Share
100
Aug 03 2022
BUY
Open market or private purchase
$13,531 $7.48 p/Share
1,809
Jul 27 2022
BUY
Open market or private purchase
$65,503 $7.91 p/Share
8,281
Jul 26 2022
BUY
Open market or private purchase
$115,172 $7.71 p/Share
14,938
Jun 21 2022
BUY
Open market or private purchase
$2,413 $7.99 p/Share
302
Jun 14 2022
BUY
Open market or private purchase
$489,549 $7.97 p/Share
61,424
Jun 13 2022
BUY
Open market or private purchase
$158,000 $7.9 p/Share
20,000
Mar 29 2022
BUY
Open market or private purchase
$24,999,990 $15.0 p/Share
1,666,666
Mar 29 2022
BUY
Conversion of derivative security
-
1,999,997

Also insider at

KALV
KalVista Pharmaceuticals, Inc. Healthcare
Director
WVE
Wave Life Sciences Ltd. Healthcare
DRNA
Dicerna Pharmaceuticals Inc
> 10% Shareholder
RARX
Ra Pharmaceuticals, Inc.
Director
EIDX
Eidos Therapeutics, Inc.
Director
ARVN
ARVINAS, INC. Healthcare
KALA
Kala Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
THOR
Synthorx, Inc.
> 10% Shareholder
SCPH
scPharmaceuticals Inc. Healthcare
> 10% Shareholder
STSA
Satsuma Pharmaceuticals, Inc. Healthcare
ETNB
89bio, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
PHAT
Phathom Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
VSTM
Verastem, Inc. Healthcare
> 10% Shareholder
FMTX
Forma Therapeutics Holdings, Inc. Healthcare
Director
RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
AKUS
Akouos, Inc. Healthcare
> 10% Shareholder
NKTX
Nkarta, Inc. Healthcare
PAND
Pandion Therapeutics, Inc.
> 10% Shareholder
INZY
Inozyme Pharma, Inc. Healthcare
> 10% Shareholder
ITOS
iTeos Therapeutics, Inc. Healthcare
INBX
Inhibrx, Inc. Healthcare
> 10% Shareholder
TGTX
TG THERAPEUTICS, INC. Healthcare
> 10% Shareholder
DYN
Dyne Therapeutics, Inc. Healthcare
> 10% Shareholder
PMVP
PMV Pharmaceuticals, Inc. Healthcare
> 10% Shareholder
PCVX
Vaxcyte, Inc. Healthcare
> 10% Shareholder
ORTX
Orchard Therapeutics plc Healthcare
Director
ITRM
Iterum Therapeutics plc Healthcare
> 10% Shareholder
VOR
Vor Biopharma Inc. Healthcare
SLDB
Solid Biosciences Inc. Healthcare
Director
HOWL
Werewolf Therapeutics, Inc. Healthcare
JANX
Janux Therapeutics, Inc. Healthcare
PNT
POINT Biopharma Global Inc. Healthcare
Director
AVTE
Aerovate Therapeutics, Inc. Healthcare
ABOS
Acumen Pharmaceuticals, Inc. Healthcare
CTKB
Cytek Biosciences, Inc. Healthcare
Director
ICVX
Icosavax, Inc. Healthcare
ELYM
Eliem Therapeutics, Inc. Healthcare
TYRA
Tyra Biosciences, Inc. Healthcare
DICE
DICE Therapeutics, Inc. Healthcare
PEPG
PepGen Inc. Healthcare
SBTX
Silverback Therapeutics, Inc. Healthcare
ACRV
Acrivon Therapeutics, Inc.
FULC
Fulcrum Therapeutics, Inc. Healthcare
MLYS
Mineralys Therapeutics, Inc.
BDTX
Black Diamond Therapeutics, Inc. Healthcare
Director
GRPH
Graphite Bio, Inc. Healthcare
BOLD
Boundless Bio, Inc.
CDTX
Cidara Therapeutics, Inc. Healthcare
RTVA
Artiva Biotherapeutics, Inc.
BCAX
Bicara Therapeutics Inc.
SEPN
Septerna, Inc.
FDMT
4D Molecular Therapeutics, Inc. Healthcare
RCM

Ra Capital Management, L.P.

Boston, MA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX